The Effects of Antipsychotics and Selective Serotonin Reuptake Inhibitors on the Development of Long Covid in a Large Veteran Population DOI
Jerry Bradley, Fei Tang, Dominique M. Tosi

et al.

Published: Jan. 1, 2024

Language: Английский

Serotonergic psychedelics as potential therapeutics for post-COVID-19 syndrome (or Long COVID): A comprehensive review DOI
Zhen Xuen Brandon Low, Shin Jie Yong, Hayam Ali AlRasheed

et al.

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Journal Year: 2025, Volume and Issue: unknown, P. 111279 - 111279

Published: Feb. 1, 2025

Language: Английский

Citations

0
No reduced serum serotonin levels in patients with post-acute sequelae of COVID-19 DOI Creative Commons
Philipp Mathé, Veronika Götz,

Katarina Stete

et al.

Infection, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 2, 2024

Language: Английский

Citations

1
Predicting Long COVID in the National COVID Cohort Collaborative Using Super Learner: Cohort Study (Preprint) DOI Creative Commons
Zachary Butzin-Dozier, Yunwen Ji, Haodong Li

et al.

JMIR Public Health and Surveillance, Journal Year: 2024, Volume and Issue: 10, P. e53322 - e53322

Published: May 16, 2024

Postacute sequelae of COVID-19 (PASC), also known as long COVID, is a broad grouping range long-term symptoms following acute COVID-19. These can occur across biological systems, leading to challenges in determining risk factors for PASC and the causal etiology this disorder. An understanding characteristics that are predictive future valuable, inform identification high-risk individuals preventative efforts. However, current knowledge regarding limited.

Language: Английский

Citations

0
The Effects of Antipsychotics and Selective Serotonin Reuptake Inhibitors on the Development of Long Covid in a Large Veteran Population DOI
Jerry Bradley, Fei Tang, Dominique M. Tosi

et al.

Published: Jan. 1, 2024

Language: Английский

Citations

0